Skip to content

Peru Longitudinal Study

Longitudinal Evaluation of Disease Prevalence in Impoverished Communities of Lima, Peru

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03742219
Enrollment
861
Registered
2018-11-15
Start date
2017-06-05
Completion date
2020-03-01
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Diabetes Mellitus, Dyslipidemias, Hypertension, Overweight and Obesity

Brief summary

The purpose of this study is to evaluate the change in disease prevalence over time in impoverished urban communities in Lima, Peru.

Detailed description

The aim is to track the changes in disease prevalence of people living in impoverished urban communities in Lima over the next 10 years. Based on data collected in prior years and in an ongoing manner, Ohio University Global Health teams will be introducing interventions focused to positively impact disease states and trends in this population. The current focus is on chronic lifestyle related diseases and their precursors: cardiovascular disease, hypertension, dyslipidemia, diabetes, and overweight / obesity.

Interventions

BEHAVIORALLifestyle Modification

1. Community awareness: a) individuals will be made aware of their own chronic lifestyle diseases and risk factors b) communities will be made aware of their aggregated data concerning chronic lifestyle related diseases and risk factors. 2. Education for individuals and communities on the meaning of the lifestyle diseases and risk factors. a) individual and small group sessions explaining diseases and lifestyle measures that are helpful, b) community level education to tentatively include i) shopping guides and recipes, ii) urban gardening projects, iii) puppet shows and other community presentations, iv) literature and posters.

Sponsors

Ohio University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* minors age 12-17 presenting to the free community clinic, with a responsible adult who can give consent; minors will give assent. * consenting adults of any age who present to the clinic.

Exclusion criteria

* adults who are unable to give consent.

Design outcomes

Primary

MeasureTime frameDescription
Triglyceridesperiodically over 10 yearsmeasured in percent via fingerstick capillary blood and portable analyzer
Systolic blood pressureyearly for 10 yearsmeasured with a manual sphygmomanometer in millimeters of mercury
Diastolic Blood Pressureyearly for 10 yearsmeasured with a manual sphygmomanometer in millimeters of mercury
glycosylated hemoglobinperiodically over 10 yearsmeasured in percent via fingerstick capillary blood and portable analyzer
Total cholesterolperiodically over 10 yearsmeasured in percent via fingerstick capillary blood and portable analyzer
Low-density lipoprotein cholesterolperiodically over 10 yearsmeasured in percent via fingerstick capillary blood and portable analyzer
High density lipoprotein cholesterolperiodically over 10 yearsmeasured in percent via fingerstick capillary blood and portable analyzer
Weightyearly for 10 yearsweight in kilograms will be utilized to determine body mass index

Secondary

MeasureTime frameDescription
Herth Hope Indexyearly for 10 yearsvalidated survey utilized to evaluate level of hope for the future
Household hunger scaleyearly for 10 yearsvalidated survey to measure food insecurity
Patient Health Questionnaire - 4 (PHQ-4)yearly for 10 yearsused to evaluate depression and anxiety
Exercise vital signyearly for 10 yearsthe minutes of exercise during the last week
24 hour dietary recallyearly for 10 yearsreport of all foods consumed in the last 24 hours, which will be utilized to determine the nutritional value of dietary intake
Perceived Stress Scaleyearly for 10 yearsvalidated survey to evaluate level of stress

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026